Incorrect, his reporting is used by shorters though.The guy that's a known biotech shorter??
Incorrect, his reporting is used by shorters though.The guy that's a known biotech shorter??
He literally came to this message board because he Googled leronlimab due to his interest in shorting the stock. He even choose the username "Whyatt" who is the brother/nemesis of Chet in the movie Weird Science. His intentions have always been suspect. I still appreciate hearing his opinions. I'll divest from CYDY in a heartbeat if I hear a persuasive argument against leronlimab.It is odd that he joined in February and most of his posts are only in this thread.
Why would they criticize it? It’s off the radar. It’s incumbent on CYDY to get it on the radar for criticism.How do Dr Otto Yang of UCLA, Dr. Manisha Juthani of Yale, and Dr. Harish Seethamraju of Montefiore have an interest in the stock? Can you name one credible source that has criticized leronlimab in any matter?
Incorrect, his reporting is used by shorters though.
 
 
   
 So all this time you professed to be an expert and you just got all your info from him? Makes sense now.Incorrect, his reporting is used by shorters though.
Why would dropping news before the presser be any different than during the presser? Anything that majorly affects the stock price isn't supposed to be released during market hours.Somebody on twitter speculates that cydy will drop some news before the presser as they can’t break news during the event. Would make for an interesting day.![]()
And here I thought he was a fan of Verizon.He literally came to this message board because he Googled leronlimab due to his interest in shorting the stock. He even choose the username "Whyatt" who is the brother/nemesis of Chet in the movie Weird Science. His intentions have always been suspect. I still appreciate hearing his opinions. I'll divest from CYDY in a heartbeat if I hear a persuasive argument against leronlimab.
There’s no news coming todaySomebody on twitter speculates that cydy will drop some news before the presser as they can’t break news during the event. Would make for an interesting day.![]()
I have no idea lol just a few people spewing stuff on the Interwebs.Why would dropping news before the presser be any different than during the presser? Anything that majorly affects the stock price isn't supposed to be released during market hours.
I sure hope. I may exit at $3200. Great stock and company, but the last time Cappy was around and questioning the value, we got a nice pullback to re-acquired.Good question. Beginning of this year the targets were $2400 and I would have been ecstatic with that this year. That’s in the mirror. I did sell some once it hit $3000 as I’m more than happy with that level and I’ve got some expenses coming up (i.e. college). I won’t be selling more anytime soon, but a pullback would be based on the quarterly reports. Their businesses are doing well in this environment and I don’t see much to worry about. Walmart’s Prime offering is basically their Instacart (I think they use them) and their in store pickup/delivery is still just mediocre. I ordered a phone case 4 times on their web site last week while on vacation for same day pickup. It was cancelled 3 times due to not being in stock, but seeing as how they gave me an iPhone 11 Pro case instead of the 11 case I ordered (I double checked) in try 4, to all the cancellations may have been manual mistakes.
At this point, I don’t have a feeling on where they are heading. I’d think they’ll stagnate for a bit. They ran through 2k, but it was stuck there for a year and a half. I think this run up will get stuck here for a bit and maybe go as low as 2500 if the overall stock market dips. I just can’t imagine it marching much more at this point. I think all stocks will be pausing again for a bit.
Same chunk bought back at 9.90Sold my chunk of 9.95 cost BLMN to free up some cash.
Hopefully this will spur a run up to 12 for everyone.
Exactly!I sure hope. I may exit at $3200. Great stock and company, but the last time Cappy was around and questioning the value, we got a nice pullback to re-acquired.
Is this true for OTC stocks also?Why would dropping news before the presser be any different than during the presser? Anything that majorly affects the stock price isn't supposed to be released during market hours.
Was $2800. I may revise that upward as it climbs much further from here.Exactly!
what’s your buy-in price?
Good question. I don't know.Is this true for OTC stocks also?
equilibriumAll I really want to know is if @chet is still at equilibrium. That’s last I recall seeing, but would love a confirmation... That would put some of my anxiety to rest.
I won't but because he came here only to discourage people from listening to chet. I want to know who he is and his motives. But I will just block him and consider him a troll.Why?
Wife just sunk 15k there.PPL looking great with a 6.8% dividend right now. Buy some in your retirement accounts.
Interesting it is off 5% on no news that I can find.PPL looking great with a 6.8% dividend right now. Buy some in your retirement accounts.
Read Dr. Patterson's paper and you will see it did work on every patient in the study--even those who did die.I don’t think so. Did he guarantee that drug will work, be approved and change the course of the virus? Or has he looked at lab results and is optimistic?
I think Dr Lazzari was the one who said it worked in every patient, even the ones that died.
Almost there....Added more DFS under 47. Have a feeling I may be buying again under 46, under 45...
Wrong and easily misinterpreted. The company registered his stock so it can now be sold--I know several people on that list and they had no idea that the company was going to make that filing. The filing in no way means they sold stock.Was Dr Patterson on the list of those selling stock? The answer to this is yes.
Love it at these levelsPPL looking great with a 6.8% dividend right now. Buy some in your retirement accounts.
Adam Feuerstein is a paid shill for Gilead and has been completely wrong on CYDY. He purposely misinterprets anything CYDY says and IMO has lost all credibility. That you are referencing him seriously detracts from your credibility as well.Substance?
https://mobile.twitter.com/adamfeuerstein/status/1280963778478321669
I completely agree with Adam’s take
DFS now in the $46 range.
Added more DFS under 47. Have a feeling I may be buying again under 46, under 45...
Added at $46.25 (thanks to selling part of the onion yesterday)DFS just leaked under 47.
I'm still up (err, basically flat), but the markets are down over 1%Good to see CYDY at least positive!
That said, nice rally today. AMZN is a juggernaut, but ROKU, LVGO, ZS and FSLY nicely up. So glad after being an idiot watching LVGO in the 20s that I jumped in at 60. Can’t believe it went to 100 in a month. Should have bought more. FSLY is my best stock ever. Bought twice so a cost basis of 17 and it’s at 100 today. Ridiculous for 8 months. Again, should have bought more when I added in March.
Hey Adam--why don't you read the list of Maraviroc's side effects and then compare them to leronlimab's side effects. I will post them below.
Common side effects of Selzentry (Maraviroc) include stomach pain, diarrhea, constipation, tiredness, lightheadedness or dizziness while standing, cold symptoms (stuffy nose, sneezing, cough, sore throat), sleep problems (insomnia), swelling, problems with urination, muscle or joint pain, or skin rash.
In the ongoing CD03 trial of leronlimab monotherapy, preliminary data was presented on 226 participants in the 350-mg dose group, 115 participants in the 525-mg dose group, and 43 participants in the 700-mg dose group. Thus far, the incidence and severity of AEs have not been dose-proportional. Most AEs were mild in intensity and no AE pattern was observed. None of the SAEs that occurred were definitely or probably related to leronlimab. The majority of injection site reactions were mild and self-resolving.4,15
Just made my 2nd buy of DFS today. Have a 3rd limit set at 45.Added at $46.25 (thanks to selling part of the onion yesterday)
Lol. I wasn’t even paying attention to the market. and my over 1% gain is back down to 0.16% up which is good now that I see where the markets are.I'm still up (err, basically flat), but the markets are down over 1%
Again, you're showing your inexperience and I am now thinking you have some agenda you're not admitting. Peer review of a paper is usually a minimum of 6-12 months.Why would they criticize it? It’s off the radar. It’s incumbent on CYDY to get it on the radar for criticism.
The peer reviewed paper would be a start, it’s still not issued yet. CYDY should be answering why not. I doubt that they will.
Sold some stock to buy about $10k worth PPL in an IRA.Love it at these levels
Yeah, a member since February who has posted almost exclusively in this thread and all negative on cytoden hence Cav saying he was gonna find out who he is.Again, you're showing your inexperience and I am now thinking you have some agenda you're not admitting. Peer review of a paper is usually a minimum of 6-12 months.